Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Gocovri (amantadine) and Rytary (carbidopa/levodopa) are both used to treat symptoms of Parkinson's disease (PD), but they work in different ways. Gocovri is an NMDA antagonist that helps manage dyskinesia and "off" episodes by raising dopamine levels in the brain. It's taken once a day at night. Common side effects include hallucinations, dizziness, and dry mouth. Rytary, on the other hand, is a combination of carbidopa and levodopa. It works by replacing dopamine and preventing its breakdown, and it's taken three times a day. Common side effects include nausea, headache, and dizziness. Unlike Gocovri, Rytary is not available in a generic form, which can make it more expensive. Both medications can cause sleepiness and should not be stopped suddenly due to the risk of severe withdrawal symptoms.
Gocovri (amantadine)
Rytary (carbidopa / levodopa)
Gocovri (amantadine)
Rytary (carbidopa / levodopa)
Summary of Gocovri vs. Rytary
Summary for NMDA antagonist
Prescription only
Gocovri (amantadine) is an NMDA antagonist. It's taken by adults with Parkinson’s disease (PD) to ease sudden uncontrolled movements (dyskinesia) caused by levodopa-containing PD medications. It can also help prevent "off" episodes of levodopa/carbidopa medications, like Sinemet. Gocovri (amantadine) is taken by mouth once a day at nighttime. Common side effects of this medication include hallucinations, dizziness, and dry mouth.
Summary for Dopa decarboxylase inhibitor / Dopamine replacement
Prescription only
Rytary (carbidopa / levodopa) is a combination medication that's used to treat adults with symptoms of Parkinson's disease (PD), such as stiff muscles and slowed movement. It contains carbidopa (a decarboxylase inhibitor) and levodopa (a dopamine replacement) in an extended-release capsule. The typical dosage is one capsule by mouth three times a day. Common side effects include nausea, headache, and dizziness. This medication doesn't currently have a generic version, but you can get it under the brand name Rytary.
Indications of Gocovri vs. Rytary
Indications for
•Treatment of dyskinesia (uncontrolled movement) in adults with PD who're taking levodopa/carbidopa
•Treatment of “off” episodes in adults taking levodopa/carbidopa